成纤维细胞生长因子23功能和调控的研究进展

doi:10.3969/j.issn.1005-4979.2018.02.010

《口腔颌面外科杂志》

成纤维细胞生长因子23功能和调控的研究进展

朱梦娇，陈凤山

上海牙组织修复与再生工程技术中心，同济大学口腔医学院，同济大学附属口腔医院口腔正畸科，上海 200072

出版日期:2018-04-28 发布日期:2019-10-21
通讯作者: 陈凤山，教授. E-mail: orthodboy@126.com E-mail:orthodboy@126.com
作者简介:朱梦娇（1991—），女，江苏人，博士研究生. E-mail: zmjzqr@163.com
基金资助:
国家自然科学基金面上项目（81670973）

Recent Advances of the Function and Regulation of the Fibroblast Growth Factor 23

ZHU Meng-jiao, CHEN Feng-shan

Department of Orthodontics, School and Hospital of Stomatology, Tongji University, Shanghai Engineering Research Center of Tooth Restoration and Regeneration, Shanghai 200072, China

Online:2018-04-28 Published:2019-10-21

摘要/Abstract

摘要： 成纤维细胞生长因子23（FGF23）是一种由骨细胞和成骨细胞合成的分泌蛋白。成熟的FGF23蛋白被分泌到血液中，通过其主要的靶器官即肾脏来调节磷酸盐的重吸收以及维生素D代谢，从而维持机体的矿物质平衡及骨的矿化程度。体内FGF23过多主要会造成低磷酸盐血症、维生素D代谢异常、生长发育异常、佝偻病、骨软化等。相反，FGF23的缺失则会导致高磷酸盐血症、1,25(OH)2D增多、软组织钙化等。FGF23的产生和活性受到全身及局部因素对其转录水平的影响，此外还受到翻译后修饰的调控。本文主要对FGF23的结构和功能、FGF23的调控、FGF23异常相关的疾病等方面的研究进展进行了综述。

关键词: 成纤维细胞生长因子23（FGF23）； , 钙磷代谢； , 矿化

Abstract: Fibroblast Growth Factor 23(FGF23) is a secreted protein synthesized by osteocytes and osteoblasts. The mature FGF23 protein is secreted into the blood and regulates phosphate reabsorption and vitamin D metabolism through its main target organ, the kidney, thereby maintaining the body's mineral balance and bone mineralization. Excessive FGF23 in the body can cause hypophosphatemia, abnormal vitamin D metabolism, abnormal growth, rickets and osteomalacia. In contrast, the absence of FGF23 will result in hyperphosphatemia, increased 1,25(OH)2D and soft tissue calcification. The production and activity of FGF23 is influenced by systemic and local factors on its transcriptional level, and is also regulated by post-translational modifications. This article reviewed recent progresses in the structure, function and regulation of FGF23, as well as diseases related to disruption of FGF23.

Key words: Fibroblast Growth Factor 23 (FGF23), calcium and phosphate homeostasis, mineralization

中图分类号:

R782.4

朱梦娇，陈凤山. 成纤维细胞生长因子23功能和调控的研究进展[J]. 《口腔颌面外科杂志》, doi: 10.3969/j.issn.1005-4979.2018.02.010.

ZHU Meng-jiao, CHEN Feng-shan. Recent Advances of the Function and Regulation of the Fibroblast Growth Factor 23[J]. 《Journal of Oral and Maxillofacial Surgery》, doi: 10.3969/j.issn.1005-4979.2018.02.010.

https://journal06.magtech.org.cn/Jweb_joms/CN/Y2018/V28/I2/105

参考文献

[1] Grabner A, Amaral AP, Schramm K, et al. Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular Hypertrophy[J]. Cell Metab, 2015, 22(6):1020-1032.
[2] Kuro-O M, Matsumura Y, Aizawa H, et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing[J]. Nature, 1997, 390(6655):45-51.
[3] Chen G, Liu Y, Goetz R, et al. alpha-Klotho is a non-enzymatic molecular scaffold for FGF23 hormone signalling[J]. Nature, 2018, 553(7689):461-466.
[4] Shimada T, Urakawa I, Yamazaki Y, et al. FGF-23 transgenic mice demonstrate hypophosphatemic rickets with reduced expression of sodium phosphate cotransporter type IIa[J]. Biochem Biophys Res Commun, 2004, 314(2):409-414.
[5] Sitara D, Razzaque MS, Hesse M, et al. Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice[J]. Matrix Biol, 2004, 23(7):421-432.
[6] Farrow EG, Davis SI, Summers LJ, et al. Initial FGF23-mediated signaling occurs in the distal convoluted tubule[J]. J Am Soc Nephrol, 2009, 20(5):955-960.
[7] Kagi L, Bettoni C, Pastor-Arroyo EM, et al. Regulation of vitamin D metabolizing enzymes in murine renal and extrarenal tissues by dietary phosphate, FGF23, and 1,25(OH)2D3[J]. PLoS One, 2018, 13(5):e0195427.
[8] Bar L, Feger M, Fajol A, et al. Insulin suppresses the production of fibroblast growth factor 23 (FGF23)[J]. Proc Natl Acad Sci U S A, 2018, 115(22):5804-5809.
[9] Beck L, Karaplis AC, Amizuka N, et al. Targeted inactivation of Npt2 in mice leads to severe renal phosphate wasting, hypercalciuria, and skeletal abnormalities[J]. Proc Natl Acad Sci U S A, 1998, 95(9):5372-5377.
[10] Sitara D, Kim S, Razzaque MS, et al. Genetic evidence of serum phosphate-independent functions of FGF-23 on bone[J]. PLoS Genet, 2008, 4(8):e1000154.
[11] Bon N, Frangi G, Sourice S, et al. Phosphate-dependent FGF23 secretion is modulated by PiT2/Slc20a2[J]. Mol Metab, 2018, 11:197-204.
[12] Haussler MR, Whitfield GK, Kaneko I, et al. The role of vitamin D in the FGF23, klotho, and phosphate bone-kidney endocrine axis[J]. Rev Endocr Metab Disord, 2012, 13(1):57-69.
[13] Nociti FH, Jr., Foster BL, Tran AB, et al. Vitamin D represses dentin matrix protein 1 in cementoblasts and osteocytes [J]. J Dent Res, 2014, 93(2):148-154.
[14] Rhee Y, Bivi N, Farrow E, et al. Parathyroid hormone receptor signaling in osteocytes increases the expression of fibroblast growth factor-23 in vitro and in vivo[J]. Bone, 2011, 49(4):636-643.
[15] Larsson T, Davis SI, Garringer HJ, et al. Fibroblast growth factor-23 mutants causing familial tumoral calcinosis are differentially processed [J]. Endocrinology, 2005, 146(9):3883-3891.
[16] Tagliabracci VS, Engel JL, Wiley SE, et al. Dynamic regulation of FGF23 by Fam20C phosphorylation, GalNAc-T3 glycosylation, and furin proteolysis[J]. Proc Natl Acad Sci U S A, 2014, 111(15):5520-5525.
[17] Zhang Q, Lin S, Liu Y, et al. Dmp1 null mice develop a unique osteoarthritis-like phenotype[J]. Int J Biol Sci, 2016, 12(10):1203-1212.
[18] Kinoshita S, Kawai M. The FGF23/KLOTHO regulatory network and its roles in human disorders[J]. Vitam Horm, 2016, 101:151-174.
[19] Carpenter TO, Imel EA, Ruppe MD, et al. Randomized trial of the anti-FGF23 antibody KRN23 in X-linked hypophosphatemia[J]. J Clin Invest, 2014, 124(4):1587-1597.
[20] Shalhoub V, Shatzen EM, Ward SC, et al. FGF23 neutralization improves chronic kidney disease-associated hyperparathyroidism yet increases mortality[J]. J Clin Invest, 2012, 122(7):2543-2553.

选择文件类型/文献管理软件名称

选择包含的内容

成纤维细胞生长因子23功能和调控的研究进展

Recent Advances of the Function and Regulation of the Fibroblast Growth Factor 23

PDF

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 2

编辑推荐

Metrics

本文评价

[1]	孙昊, 林超, 马旭彤, 仲若恺, 范欣. 矿化胶原联合浓缩生长因子治疗颌骨囊肿术后骨缺损的临床研究[J]. 《口腔颌面外科杂志》, 2023, 33(5): 320-325.
[2]	李静，王明国，杨世茂，刘金盼，文玉珍. rhBMP-2和FGF-2对成骨细胞矿化及ENPP1、ANK、TNAP表达的影响[J]. 《口腔颌面外科杂志》, 2012, 22(5): 333-336.

模态框（Modal）标题

选择文件类型/文献管理软件名称

选择包含的内容

成纤维细胞生长因子23功能和调控的研究进展

Recent Advances of the Function and Regulation of the Fibroblast Growth Factor 23

PDF

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 2

编辑推荐

Metrics

本文评价